About: Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2004 (uk) 2004 թվականին հրատարակված գիտական հոդված (hy) im Januar 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2004 (ast) artikull shkencor i botuar më 01 janar 2004 (sq) scientific article published on 01 January 2004 (en)
publication date	wds:Q58803398-FFE6C98E-8162-40F8-9319-893450DC7026
publication date	2004-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q58803398-29F730AD-6B7F-4A5C-AEBC-4E820B0EC81F
exact match	https://scigraph.springernature.com/pub.10.2165/00019053-200422040-00004
cites work	wds:Q58803398-05F94346-7CED-4FF4-BBC3-1901E719BC83 wds:Q58803398-1103A9DB-5FE0-4E10-AEF1-9A107C962C21 wds:Q58803398-1693BACB-3735-42F2-8FD1-DC9AB20C70FE wds:Q58803398-21C30413-9EF4-4942-85C2-1E60D9E6CC14 wds:Q58803398-6A5749E4-CD9E-436D-B539-88280D24BB50 wds:Q58803398-72E68AC8-0736-4C7B-BE3C-A5C574055425 wds:Q58803398-769621AA-318A-44FB-B555-0C303368E6E3 wds:Q58803398-7A85262C-0C72-4522-ABD1-F43206382550 wds:Q58803398-86992911-DB1D-4696-B724-D11BA3A37E1C wds:Q58803398-88672667-D258-4E69-B4EE-3EFB4108E1A6 wds:Q58803398-8CC80194-BB86-428D-BF13-D573F6D8A0DD wds:Q58803398-957ACE49-66C6-406D-8A1E-30A14C05D154 wds:Q58803398-A93F394D-AB9A-4353-A49B-3E6B5B001FB0 wds:Q58803398-AA15E5FE-C1F5-496E-9460-171E8B8C0B44 wds:Q58803398-ADAA7B4F-96F0-468F-9EAD-C111481124B1 wds:Q58803398-BC145C24-7A58-4CDD-B463-731A7F781D24 wds:Q58803398-C4B16012-0AE6-4774-9989-85676145819D wds:Q58803398-C9279940-9121-4A0D-8D30-78EF503980F4 wds:Q58803398-D01234F5-8F95-48AE-82F6-24B289F9C8BC wds:Q58803398-D985EB7C-C545-4427-98B1-CC91CAD58D05 wds:Q58803398-DFAA15B5-28D4-4365-B6E3-6D8C5C85B43E wds:Q58803398-E64E6B7F-9562-44F3-8B4A-3CD68B8219E3 wds:Q58803398-E7811127-8E23-4CB8-9F2D-F41FC088EB53 wds:Q58803398-ED4E4E85-6359-4FD1-8C66-2D4AF9568FD6 wds:Q58803398-EE68E3D8-23E8-4FA7-AF9B-0D058CA815AB wds:Q58803398-F416221E-5AA1-4BB5-9BC7-5FDFB936CAF1 wds:Q58803398-FD0F7A39-9CB5-4AD4-AEED-0DA37ACA3F7D
cites work	10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups The long-term pathological evolution of chronic hepatitis C. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I Etiology, natural history and treatment of hepatocellular carcinoma Estimating progression to cirrhosis in chronic hepatitis C virus infection. Cost effectiveness of combination therapy for hepatitis C: a decision analytic model Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group. Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C. Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C Introduction to therapy of hepatitis C. Liver transplantation for hepatitis C virus-related cirrhosis. Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C. Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden [Hepatitis C in Italy in 1992: analysis of individual reports]
author name string	wds:Q58803398-15BFF963-33CE-40D8-ABAE-8167E135DEB6 wds:Q58803398-3FC430F9-E1CE-440F-9857-427CAC226E4F wds:Q58803398-70B9880F-A9DB-44FB-9F7B-0DCF7A037957 wds:Q58803398-9285B874-788A-4636-8744-FA6B212D0AA2 wds:Q58803398-BDBFC280-6232-4913-BDB8-1BE3A3D88E31 wds:Q58803398-EB0CBF64-2DAE-4DBA-AE36-09C1B8839ED6
author name string	Sean D Sullivan Kavita K Patel Neil Wintfeld Giovanni Giuliani Jesse Green Claudio De Carli
rdfs:label	Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (en) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (nl) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (sq)
skos:prefLabel	Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (en) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (nl) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (sq)
name	Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (en) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (nl) Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (sq)
author	wds:Q58803398-42969EFA-E06B-4052-9545-6AE64AF0040F wds:Q58803398-EDCCE6D9-55BA-47FB-B864-2859E6BE69BA
author	Alfredo Alberti Antonio Craxì
title	wds:Q58803398-5FCD0F86-3404-4ADA-8DA5-7EC4F839E5BD
title	Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C (en)
page(s)	wds:Q58803398-29E30905-BAB6-4BE9-8C9D-EE8564105F39
page(s)	257-265
instance of	wds:Q58803398-F9772612-6B74-444A-903B-2B9A94A40BAC
instance of	scholarly article
main subject	wds:Q58803398-0B43494E-1E57-4B6E-8233-CDA5CD203DC4 wds:Q58803398-4665BE71-F286-468D-BE14-DB4420605E63 wds:Q58803398-626DD5B3-4B35-4285-8A9B-0B8236081094

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software